ALPHARMA INC
10-Q/A, EX-27, 2000-11-15
PHARMACEUTICAL PREPARATIONS
Previous: ALPHARMA INC, 10-Q/A, 2000-11-15
Next: SEACOAST BANKING CORP OF FLORIDA, S-8, 2000-11-15



<TABLE> <S> <C>

<ARTICLE> 5
<RESTATED>
<MULTIPLIER> 1000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                          22,046
<SECURITIES>                                         0
<RECEIVABLES>                                  211,433
<ALLOWANCES>                                         0
<INVENTORY>                                    235,796
<CURRENT-ASSETS>                               483,840
<PP&E>                                         502,573
<DEPRECIATION>                                 181,044
<TOTAL-ASSETS>                               1,488,641
<CURRENT-LIABILITIES>                          200,143
<BONDS>                                        370,119
                                0
                                          0
<COMMON>                                         7,032
<OTHER-SE>                                     524,531
<TOTAL-LIABILITY-AND-EQUITY>                 1,488,641
<SALES>                                        410,117
<TOTAL-REVENUES>                               410,117
<CGS>                                          220,999
<TOTAL-COSTS>                                  220,999
<OTHER-EXPENSES>                               131,390
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              23,913
<INCOME-PRETAX>                                 29,906
<INCOME-TAX>                                    10,497
<INCOME-CONTINUING>                             19,409
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    19,409
<EPS-BASIC>                                        .63
<EPS-DILUTED>                                      .60


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission